IAE-0972

N/A

Report date: 2025/11/25 10:32:54

Base Information

Drug NameIAE-0972
Drug Alias NameIAE-0972
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin 10 receptor agonistsEpidermal growth factor receptor erbB1 antagonists
TargetsInterleukin 10 receptorEpidermal growth factor receptor erbB1
Therapy Area/IndicationsSolid tumoursColorectal NeoplasmsNasopharyngeal Carcinoma +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesSunHo (China) BioPharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesSunHo (China) BioPharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursColorectal NeoplasmsNasopharyngeal Carcinoma +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A